Unicycive Therapeutics, Inc.UNCYNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank14
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-31.55M
↓ 117% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-14.55M
Historical baseline
PeriodValueYoY Change
TTM$-31.55M+1.7%
2024$-32.12M-54.6%
2023$-20.77M-15.1%
2022$-18.05M-101.1%
2021$-8.98M-344.4%
2020$-2.02M-2.9%
2019$-1.96M-106.2%
2018$-952000.00-